Nano-drug for regulating macrophage M2 type polarization by targeting mitochondria as well as preparation method and application of nano-drug

The invention belongs to the technical field of nano-drug materials for treating rheumatoid arthritis, and particularly relates to a nano-drug for regulating macrophage M2 type polarization by targeting mitochondria as well as a preparation method and application of the nano-drug. According to the n...

Full description

Saved in:
Bibliographic Details
Main Authors ZHOU WENHONG, LIU YUYU, WANG GUANHAI, GUO NING, CUI LIAO, CHEN JIA, LIU YUN
Format Patent
LanguageChinese
English
Published 02.04.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention belongs to the technical field of nano-drug materials for treating rheumatoid arthritis, and particularly relates to a nano-drug for regulating macrophage M2 type polarization by targeting mitochondria as well as a preparation method and application of the nano-drug. According to the nano-drug, a porous material which is relatively mature at present is used as a main carrier, and an anti-inflammatory drug is loaded into the porous material; meanwhile, the natural polyphenol modified by folic acid and 4-carboxybutyl triphenylphosphonium bromide and high-valence metal ions are subjected to a complexation reaction to form a metal-polyphenol grid structure, and the porous material loaded with the anti-inflammatory drug is packaged to prepare the anti-inflammatory drug. Wherein the folic acid can be recognized by a folic acid receptor expressed by activated macrophages, so that the nano system is swallowed into cells; the effect of treating rheumatoid arthritis through targeted mitochondrial regulati
Bibliography:Application Number: CN202311439811